Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
Med J Aust
    July 2021
  1. GRACEN L, Powell EE
    Non-alcoholic fatty liver disease: raising awareness of a looming public health problem.
    Med J Aust. 2021;215:75-76.
    >> Share

    June 2021
  2. ZAJAC JD, Andrikopoulos S
    Diabetes care for hospital patients in Australia needs repair.
    Med J Aust. 2021 Jun 28. doi: 10.5694/mja2.51160.
    >> Share

  3. PEASE AJ, Andrikopoulos S, Abraham MB, Craig ME, et al
    Utilisation, access and recommendations regarding technologies for people living with type 1 diabetes: consensus statement of the ADS/ADEA/APEG/ADIPS Working Group.
    Med J Aust. 2021 Jun 20. doi: 10.5694/mja2.51118.
    >> Share

    May 2021
  4. KIBURG KV, MacIsaac AI, Wilson A, Sundararajan V, et al
    Hospital admissions for cardiovascular complications of people with or without diabetes, Victoria, 2004-2016.
    Med J Aust. 2021 May 24. doi: 10.5694/mja2.51101.
    >> Share

  5. DONOVAN P, Eccles-Smith J, Hinton N, Cutmore C, et al
    The Queensland Inpatient Diabetes Survey (QuIDS) 2019: the bedside audit of practice.
    Med J Aust. 2021 May 3. doi: 10.5694/mja2.51048.
    >> Share

    March 2021
  6. D'EMDEN MC, Ungerer JP, de Jersey SJ
    Alternative screening protocols may miss most cases of gestational diabetes mellitus during the COVID-19 pandemic.
    Med J Aust. 2021 Mar 8. doi: 10.5694/mja2.50974.
    >> Share

    February 2021
  7. SNAITH JR, Holmes-Walker DJ
    Technologies in the management of type 1 diabetes.
    Med J Aust. 2021 Feb 28. doi: 10.5694/mja2.50946.
    >> Share

  8. HAYNES A, Curran JA, Davis EA
    Two decades of increasing incidence of childhood-onset type 2 diabetes in Western Australia (2000-2019).
    Med J Aust. 2021 Feb 27. doi: 10.5694/mja2.50970.
    >> Share

    December 2020
  9. MEYER EJ, Thiruvenkatarajan V, Jesudason D
    Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis.
    Med J Aust. 2020 Dec 21. doi: 10.5694/mja2.50899.
    >> Share

  10. HAMBLIN PS, Wong R, Bach LA
    Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis.
    Med J Aust. 2020 Dec 21. doi: 10.5694/mja2.50898.
    >> Share

    September 2020
  11. SIRU R, Conradie JH, Gillett MJ, Gianatti E, et al
    Risk of undetected cases of gestational diabetes mellitus during the COVID-19 pandemic.
    Med J Aust. 2020 Sep 10. doi: 10.5694/mja2.50776.
    >> Share

    June 2020
  12. SCOTT ES, Jenkins AJ, Fulcher GR
    Challenges of diabetes management during the COVID-19 pandemic.
    Med J Aust. 2020 Jun 24. doi: 10.5694/mja2.50665.
    >> Share

  13. PENA AS, Curran JA, Fuery M, George C, et al
    Screening, assessment and management of type 2 diabetes mellitus in children and adolescents: Australasian Paediatric Endocrine Group guidelines.
    Med J Aust. 2020 Jun 23. doi: 10.5694/mja2.50666.
    >> Share

  14. SUBASINGHE AK, Nankervis AJ, Boyle JA, Mazza D, et al
    Optimising the implementation of guidelines for the post partum testing and management of gestational diabetes in South Asian women in Australia.
    Med J Aust. 2020 Jun 11. doi: 10.5694/mja2.50660.
    >> Share

    March 2020
  15. CHEUNG NW, Campbell LV, Middleton S
    Routine glucose assessment in the emergency department for detecting unrecognised diabetes: a cluster randomised trial.
    Med J Aust. 2020 Mar 13. doi: 10.5694/mja2.50549.
    >> Share

  16. FOURLANOS S, Barmanray R, Kyi M
    Routine glucose assessment in the emergency department for detecting unrecognised diabetes: a cluster randomised trial.
    Med J Aust. 2020 Mar 13. doi: 10.5694/mja2.50550.
    >> Share

  17. HAMBLIN PS, Wong R, Bach LA
    Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis.
    Med J Aust. 2020 Mar 3. doi: 10.5694/mja2.50525.
    >> Share

    February 2020
  18. WHITE H, Tendal B, Elliott J, Turner T, et al
    Breathing life into Australian diabetes clinical guidelines.
    Med J Aust. 2020 Feb 14. doi: 10.5694/mja2.50509.
    >> Share

    January 2020
  19. LIBIANTO R, Davis TM, Ekinci EI
    Advances in type 2 diabetes therapy: a focus on cardiovascular and renal outcomes.
    Med J Aust. 2020 Jan 7. doi: 10.5694/mja2.50472.
    >> Share

  20. SINHA S, Gavaghan D, Yew S
    Euglycaemic ketoacidosis from an SGLT2 inhibitor exacerbated by a ketogenic diet.
    Med J Aust. 2020;212:46-46.
    >> Share

    December 2019
  21. CURRAN JA, Haynes A, Davis EA
    Clinical characteristics of Western Australian children diagnosed with type 2 diabetes before 10 years of age.
    Med J Aust. 2019 Dec 6. doi: 10.5694/mja2.50451.
    >> Share

    November 2019
  22. CHEUNG NW, Campbell LV, Fulcher GR, McElduff P, et al
    Routine glucose assessment in the emergency department for detecting unrecognised diabetes: a cluster randomised trial.
    Med J Aust. 2019 Nov 3. doi: 10.5694/mja2.50394.
    >> Share

    October 2019
  23. HARE MJ, Shaw JE
    Inpatient diabetes care requires adequate support, not just HbA1c screening.
    Med J Aust. 2019 Oct 31. doi: 10.5694/mja2.50391.
    >> Share

    August 2019
  24. MCLACHLAN G, Keith C, Frauman A
    Diabetic ketoacidosis with sodium-glucose cotransporter type 2 inhibitors: a case series.
    Med J Aust. 2019 Aug 16. doi: 10.5694/mja2.50302.
    >> Share

    July 2019
  25. DAVIS TM, Makepeace AE, Peters K, Colclough K, et al
    An updated prevalence of monogenic diabetes in Australia: Fremantle Diabetes Study Phase 2.
    Med J Aust. 2019 Jul 18. doi: 10.5694/mja2.50290.
    >> Share

  26. COUPER JJ, Harrison LC
    Controversies in medicine: redefining the diagnosis of type 1 diabetes.
    Med J Aust. 2019 Jul 18. doi: 10.5694/mja2.50284.
    >> Share

    January 2019
  27. ALBARQOUNI L, Doust JA, Magliano D, Barr EL, et al
    External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
    Med J Aust. 2019 Jan 18. doi: 10.5694/mja2.12061.
    >> Share

  28. TITMUSS A, Davis EA, Brown A, Maple-Brown LJ, et al
    Emerging diabetes and metabolic conditions among Aboriginal and Torres Strait Islander young people.
    Med J Aust. 2019 Jan 18. doi: 10.5694/mja2.13002.
    >> Share

    November 2018
  29. NEUEN BL, Perkovic V
    Reducing cardiovascular risk in people with diabetes and kidney disease.
    Med J Aust. 2018;209:438-439.
    >> Share

    October 2018
  30. LIM WH, Johnson DW, Hawley C, Lok C, et al
    Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
    Med J Aust. 2018 Oct 22. pii: 10.5694/mja18.00195.
    >> Share

    September 2018
  31. LAZZARINI PA, van Netten JJ, Fitridge RA, Griffiths I, et al
    Pathway to ending avoidable diabetes-related amputations in Australia.
    Med J Aust. 2018;209:288-290.
    >> Share

    July 2018
  32. BARMANRAY R, Briganti E
    Glycaemic control apps for diabetes: lifting the lid.
    Med J Aust. 2018 Jul 30. pii: 10.5694/mja18.00066.
    >> Share

    May 2018
  33. SIMMONS D, Hague WM, Teede HJ, Cheung NW, et al
    Hyperglycaemia in early pregnancy: the Treatment of Booking Gestational diabetes Mellitus (TOBOGM) study. A randomised controlled trial.
    Med J Aust. 2018 May 28. pii: 10.5694/mja17.01129.
    >> Share

    March 2018
  34. NG HY, Pape A
    Insulinoma: important in the differential diagnosis of persistent hypoglycaemia unrelated to diabetes.
    Med J Aust. 2018;208:157-158.
    >> Share

    February 2018
  35. LAKE AJ, Browne JL, Speight J
    Adherence to diabetic eye examination guidelines in Australia: the National Eye Health Survey.
    Med J Aust. 2018;208:97.
    >> Share

  36. FOREMAN J, Keel S, Dirani M
    Adherence to diabetic eye examination guidelines in Australia: the National Eye Health Survey.
    Med J Aust. 2018;208:97.
    >> Share

    October 2017
  37. DAVIS TM, Makepeace AE, Ellard S, Colclough K, et al
    The prevalence of monogenic diabetes in Australia: the Fremantle Diabetes Study Phase II.
    Med J Aust. 2017;207:344-347.
    >> Share

  38. CHOW E, Chan JC
    Explaining the high prevalence of young-onset diabetes among Asians and Indigenous Australians.
    Med J Aust. 2017;207:331-332.
    >> Share

    August 2017
  39. BISHAY RH, Greenfield JR
    A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY.
    Med J Aust. 2017;207:223.
    >> Share

  40. FLACK JR, Ross GP, Cheung NW
    A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY.
    Med J Aust. 2017;207:223.
    >> Share

  41. PAUL CL, Ishiguchi P, D'Este CA, Shaw JE, et al
    Testing for type 2 diabetes in Indigenous Australians: guideline recommendations and current practice.
    Med J Aust. 2017;207:206-210.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016